DEFICIENT INTERLEUKIN-2-ACTIVATED KILLER CELL CYTO-TOXICITY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:6
作者
FROELICH, CJ [1 ]
GUIFFAUT, S [1 ]
SOSENKO, M [1 ]
MUTH, K [1 ]
机构
[1] ABBOTT LABS,N CHICAGO,IL 60064
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1989年 / 50卷 / 01期
关键词
D O I
10.1016/0090-1229(89)90228-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:132 / 145
页数:14
相关论文
共 31 条
[21]  
RUBIN LA, 1986, J IMMUNOL, V137, P3841
[22]   PHA-INDUCED CELLULAR CYTOTOXICITY - INHIBITION BY A NON-IMMUNOGLOBULIN FACTOR PRESENT IN SERA FROM PATIENTS WITH ACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
RUIZARGUELLES, A ;
DIAZJOUANEN, E ;
ALARCONSEGOVIA, D .
ARTHRITIS AND RHEUMATISM, 1979, 22 (01) :59-65
[23]   ABNORMAL INTERFERON MODULATION OF NATURAL CYTO-TOXICITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - RELATION TO SUPPRESSIVE SERUM FACTORS [J].
SIBBITT, WL ;
FROELICH, CJ ;
BANKHURST, AD .
ARTHRITIS AND RHEUMATISM, 1983, 26 (12) :1452-1459
[24]   THE IL-2 RECEPTOR BETA-CHAIN (P70) - ROLE IN MEDIATING SIGNALS FOR LAK, NK, AND PROLIFERATIVE ACTIVITIES [J].
SIEGEL, JP ;
SHARON, M ;
SMITH, PL ;
LEONARD, WJ .
SCIENCE, 1987, 238 (4823) :75-78
[25]   ABNORMALITIES IN AUTOLOGOUS MIXED LYMPHOCYTE REACTION-ACTIVATED IMMUNOLOGICAL PROCESSES IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND THEIR POSSIBLE CORRECTION BY INTERLEUKIN-2 [J].
TAKADA, S ;
UEDA, Y ;
SUZUKI, N ;
MURAKAWA, Y ;
HOSHINO, T ;
GREEN, I ;
STEINBERG, AD ;
HORWITZ, DA ;
SAKANE, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1985, 15 (03) :262-267
[26]   SPECIAL ARTICLE - THE 1982 REVISED CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
TAN, EM ;
COHEN, AS ;
FRIES, JF ;
MASI, AT ;
MCSHANE, DJ ;
ROTHFIELD, NF ;
SCHALLER, JG ;
TALAL, N ;
WINCHESTER, RJ .
ARTHRITIS AND RHEUMATISM, 1982, 25 (11) :1271-1277
[27]   CYTO-TOXIC RESPONSES TO ALLOANTIGENS IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
TSOKOS, GC ;
BALOW, JE .
JOURNAL OF CLINICAL IMMUNOLOGY, 1981, 1 (04) :208-216
[28]   INTERLEUKIN-2 RESTORES THE DEPRESSED ALLOGENEIC CELL-MEDIATED LYMPHOLYSIS AND NATURAL-KILLER CELL-ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
TSOKOS, GC ;
SMITH, PL ;
CHRISTIAN, CB ;
LIPNICK, RN ;
BALOW, JE ;
DJEU, JY .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1985, 34 (03) :379-386
[29]  
TSOKOS GC, 1984, PROG ALLERGY, V35, P93
[30]  
VOLK HD, 1986, CLIN EXP IMMUNOL, V66, P525